Beyond Air, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $17.00K.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was -$17.00K.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $217.00K.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for fiscal 2026 was $2.87M, a 685.75% increase from fiscal 2025.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $365.00K, a 68.20% increase from fiscal 2024.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $217.00K.
- Beyond Air, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $1.00K, a 99.53% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $2.87M 10-K · filed 2026-06-26 | |
| 2025-03-31 | $365.00K 10-K · filed 2026-06-26 | |
| 2024-03-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $217.00K 10-K · filed 2025-06-20 |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | |
| 2023-09-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | |
| 2023-06-30 | $217.00K 10-Q · filed 2025-02-10 | |
| 2021-12-31 | $149.00K 10-Q · filed 2023-02-10 | |
| 2021-09-30 | $50.00K 10-Q · filed 2023-02-10 | |
| 2021-03-31 | $1.00K 10-K · filed 2022-06-29 | |
| 2020-06-30 | $1.00K 10-Q · filed 2022-02-10 | |
| 2020-03-31 | $210.65K 10-K · filed 2021-06-10 | |
| 2019-12-31 | $8.17K 10-Q · filed 2021-02-09 | |
| 2019-09-30 | $25.93K 10-Q · filed 2021-02-09 | |
| 2019-06-30 | $83.86K 10-Q · filed 2021-02-09 | |
| 2019-03-31 | $8.70K 10-K · filed 2020-06-23 | |
| 2017-12-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15 | $1.00K 10-KT · filed 2018-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |